Adachi, 2002, The effect of antibiotics on the production of superantigen from Staphylococcus aureus isolated from atopic dermatitis, J. Dermatol. Sci., 28, 76, 10.1016/S0923-1811(01)00143-8
Benseler, 2005, Infections and Kawasaki disease: implications for coronary artery outcome, Pediatrics, 116, e760, 10.1542/peds.2005-0559
Bindea, 2009, ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks, Bioinformatics, 25, 1091, 10.1093/bioinformatics/btp101
Burns, 2004, Kawasaki syndrome, Lancet, 364, 533, 10.1016/S0140-6736(04)16814-1
Carapetis, 2014, Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections, Clin. Infect. Dis., 59, 358, 10.1093/cid/ciu304
Chang, 2019, Comprehensive analyses of DNA methylation and gene expression profiles of Kawasaki disease, J. Cell. Biochem., 120, 13001, 10.1002/jcb.28571
Esper, 2005, Association between a novel human coronavirus and Kawasaki disease, J. Infect. Dis., 191, 499, 10.1086/428291
Hamada, 2016, Comprehensive pathogen detection associated with four recurrent episodes of Kawasaki disease in a patient during a single year using next-generation sequencing, JMM Case Rep., 3, 10.1099/jmmcr.0.005019
Han, 2018, Antibiotic use in children with Kawasaki disease, World J. Pediatr., 14, 621, 10.1007/s12519-018-0157-3
Hattori, 2005, Adult Kawasaki disease unrelated to Epstein-Barr virus and group A Streptococcus, Intern. Med., 44, 1182, 10.2169/internalmedicine.44.1182
Hoang, 2014, Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease, Genome Med., 6, 541, 10.1186/s13073-014-0102-6
Hur, 2019, Infliximab treatment for intravenous immunoglobulin-resistant Kawasaki disease: a multicenter study in Korea, Korean Circ. J., 49, 183, 10.4070/kcj.2018.0214
Itoh, 2015, Enhancement of neutrophil autophagy by an IVIG preparation against multidrug‐resistant bacteria as well as drug‐sensitive strains, J. Leukoc. Biol., 98, 107, 10.1189/jlb.4A0813-422RRR
Jaggi, 2018, Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease, PLoS One, 13, 10.1371/journal.pone.0197858
Kawasaki, 1974, A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan, Pediatrics, 54, 271, 10.1542/peds.54.3.271
Kim, 2018, Factors predicting resistance to intravenous immunoglobulin treatment and coronary artery lesion in patients with Kawasaki disease: analysis of the Korean nationwide multicenter survey from 2012 to 2014, Korean Circ. J., 48, 71, 10.4070/kcj.2017.0136
Langfelder, 2008, WGCNA: an R package for weighted correlation network analysis, BMC Bioinformatics, 9, 559, 10.1186/1471-2105-9-559
Lau, 2009, Inhibition of matrix metalloproteinase‐9 activity improves coronary outcome in an animal model of Kawasaki disease, Clin. Exp. Immunol., 157, 300, 10.1111/j.1365-2249.2009.03949.x
Leahy, 2012, Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneumonia: a case report, Can. J. Infect. Dis. Med. Microbiol., 23, 137, 10.1155/2012/638357
Ma, 2018, MetaOmics: analysis pipeline and browser-based software suite for transcriptomic meta-analysis, Bioinformatics
Mori, 2001, Two-generation Kawasaki disease: mother and daughter, J. Pediatr., 139, 754, 10.1067/mpd.2001.118426
Nagata, 2009, Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease, Immunology, 128, 511, 10.1111/j.1365-2567.2009.03135.x
Ogata, 2009, Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone, Pediatr. Res., 66, 577, 10.1203/PDR.0b013e3181baa3c2
Ogihara, 2014, Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance, Pediatr. Res., 76, 287, 10.1038/pr.2014.92
Rahmati, Y., et al., Identification of 7 key age-related genes involved in Kawasaki disease, an integrated study by metaDE and weighted gene co-expression network analysis.
Russo, 2018, CEMiTool: a Bioconductor package for performing comprehensive modular co-expression analyses, BMC Bioinformatics, 19, 56, 10.1186/s12859-018-2053-1
Sallam, 2016, A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria, Infect. Drug Resist., 9, 301, 10.2147/IDR.S120227
Sedgwick, 2012, Pearson’s correlation coefficient, Bmj, 345, e4483, 10.1136/bmj.e4483
Shannon, 2003, Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res., 13, 2498, 10.1101/gr.1239303
Shimizu, 2011, Transforming growth factor-β signaling pathway in patients with Kawasaki disease, Circ. Cardiovasc. Genet., 4, 16, 10.1161/CIRCGENETICS.110.940858
Verma, 2018, Recurrent kawasaki disease presenting to dentists:“Think beyond dentition, Int. J. Clin. Pediatr. Dent., 11, 532
Wright, 2018, Diagnosis of Kawasaki disease using a minimal whole-blood gene expression signature, JAMA Pediatr., 172, 10.1001/jamapediatrics.2018.2293
Xing, 2015, Exploring the genes associated with the response to intravenous immunoglobulin in patients with Kawasaki disease using DNA microarray analysis, Exp. Mol. Pathol., 98, 7, 10.1016/j.yexmp.2014.11.006
Yu, 2018
Yu, 2012, clusterProfiler: an R package for comparing biological themes among gene clusters, Omics A J. Integr. Biol., 16, 284, 10.1089/omi.2011.0118